论文部分内容阅读
芬氟拉敏的减肥作用已被证实,近年来,它的降糖作用开始受到重视。本组观察了Ⅱ型糖尿病患者24例,现将这些病人在不改变原来饮食并同时应用降糖药物条件下,加用芬氟拉敏三个月前后的结果简报如下:(1)血糖从服药前199.1±54.34mg/dl,3月后降至141.04±31.68mg/dl(P<0.001),体重变化与血糖下降之间经统计学处理未发现相关性。(2)糖耐量试验:服药前后各时相比较均有明显差别。(3)糖化血浆蛋白(GPP)服药前后比较有显著差别。(4)胰岛素及胰升糖素释放试验:服药前后各时相及释放面积
Fenfluramine weight loss has been confirmed in recent years, its hypoglycemic effect began to receive attention. This group observed 24 patients with type 2 diabetes, these patients now do not change the original diet and at the same time under the conditions of hypoglycemic drugs, plus Fenfluramine three months after the results of the briefing is as follows: (1) Before 199.1 ± 54.34mg / dl, after March dropped to 141.04 ± 31.68mg / dl (P <0.001), no correlation was found between the change of body weight and the decline of blood glucose. (2) glucose tolerance test: Before and after taking the time were significantly different. (3) Glycosylated plasma protein (GPP) before and after taking a significant difference. (4) insulin and glucagon release test: before and after taking the time phase and release area